米托蒽醌 (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "米托蒽醌" in Chinese language version.
refsWebsite
Global rank
Chinese rank
5th place
12th place
doi.org
- Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, Ancliff P, Morgan M, Masurekar A, Goulden N, Green N, Révész T, Darbyshire P, Love S, Saha V. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet. 2010, 376 (9757): 2009–2017. PMC 3010035
. PMID 21131038. doi:10.1016/S0140-6736(10)62002-8. - Fox E. Management of worsening multiple sclerosis with mitoxantrone: a review. Clin Ther. 2006, 28 (4): 461–74. PMID 16750460. doi:10.1016/j.clinthera.2006.04.013.
- Fox, E. J. Mechanism of action of mitoxantrone. Neurology. 2004, 63 (12 Suppl 6): S15–S18. PMID 15623664. doi:10.1212/WNL.63.12_suppl_6.S15.
- Murdock, K. C.; Child, R. G.; Fabio, P. F.; Angier, Robert D.; Wallace, Roslyn E.; Durr, Frederick E.; Citarella, R. V. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones. Journal of Medicinal Chemistry. 1979, 22 (9): 1024. PMID 490545. doi:10.1021/jm00195a002.
nih.gov
ncbi.nlm.nih.gov
- Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, Ancliff P, Morgan M, Masurekar A, Goulden N, Green N, Révész T, Darbyshire P, Love S, Saha V. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet. 2010, 376 (9757): 2009–2017. PMC 3010035 . PMID 21131038. doi:10.1016/S0140-6736(10)62002-8.
- Fox E. Management of worsening multiple sclerosis with mitoxantrone: a review. Clin Ther. 2006, 28 (4): 461–74. PMID 16750460. doi:10.1016/j.clinthera.2006.04.013.
- Mazerski J, Martelli S, Borowski E. The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: molecular dynamics simulations. Acta Biochim. Pol. 1998, 45 (1): 1–11. PMID 9701490.
- Fox, E. J. Mechanism of action of mitoxantrone. Neurology. 2004, 63 (12 Suppl 6): S15–S18. PMID 15623664. doi:10.1212/WNL.63.12_suppl_6.S15.
- Murdock, K. C.; Child, R. G.; Fabio, P. F.; Angier, Robert D.; Wallace, Roslyn E.; Durr, Frederick E.; Citarella, R. V. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones. Journal of Medicinal Chemistry. 1979, 22 (9): 1024. PMID 490545. doi:10.1021/jm00195a002.
worldcat.org
- Katzung, Bertram G. Cancer Chemotherapy. Basic and clinical pharmacology 10th. New York: McGraw-Hill Medical Publishing Division. 2006. ISBN 0-07-145153-6. OCLC 157011367.